Mutational Analysis in Early-Onset Familial Dementia in the Japanese Population

Takeshi Ikeuchi, Hiroyuki Kaneko, Akinori Miyashita, Hiroaki Nozaki, Kensaku Kasuga, Tamao Tsukie, Miyuki Tsuchiya, Toru Imamura, Hideki Ishizu, Kenju Aoki,

Dementia and Geriatric Cognitive Disorders · 2008 · 59 citations · 23 references

Concepts

Abstract

<i>Background:</i> Three major causative genes have been implicated as the cause of early-onset familial Alzheimer’s disease (AD): the amyloid precursor protein gene <i>(APP)</i>, presenilin-1 <i>(PSEN1)</i> and <i>PSEN2</i>. Although rare, a tau-related dementia with mutations in the microtubule-associated protein tau gene <i>(MAPT)</i> has been identified in patients showing clinical presentations similar to those of AD. <i>Methods:</i> We performed mutational analysis of <i>APP</i>, <i>PSEN1</i>, <i>PSEN2</i>, and <i>MAPT</i> in 10 Japanese families with early-onset dementia clinically diagnosed as probable Alzheimer’s disease. <i>Results:</i> In 4 index patients, we identified 4 missense <i>PSEN1</i> mutations, namely, L286V, G378E, L381V, and L392V. The mean age at onset in the patients with <i>PSEN1</i> mutations was 39 years. In 2 families, we found the R406W mutation in <i>MAPT</i>. The mean age at onset of the patients carrying the R406W mutation was 52 years, and they presented with the peculiar AD-like phenotype without apparent behavioral or language problems. <i>Conclusion:</i> These observations suggest that although <i>PSEN1</i> mutations are the most frequent cause, the <i>MAPT</i> R406W mutation is an important cause of early-onset familial dementia clinically diagnosed as AD. Differentiation of patients with the<i> MAPT</i> mutation from AD patients by genetic testing would be meaningful, considering that a different therapeutic approach should be applied.

References

23